Transitioning insomnia patients from zolpidem to lemborexant: A multicenter, open-label study evaluating a next-dose transition approach to insomnia pharmacotherapy
Objective: Few clinical studies have assessed real-world abrupt transitioning between insomnia medications. This study assessed strategies for directly transitioning patients from zolpidem tartrate (ZOL) immediate/extended release to the dual orexin receptor antagonist, lemborexant (LEM). Methods: T...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2024-12-01
|
| Seri Bilgileri: | Sleep Medicine: X |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2590142723000381 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|